CD8A and neoplasm: LSD1 inhibition (GSK2879552) rescues the Id2-deficient phenotype in tumor models (44), expanding Slamf6+Tim-3- Texprog cells and enhancing Tcf1 expression in Id2-deficient CD8+ T cells (45).